MétaCan
Menu
Back to cohort

Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization

2024· article· en· W4394690774 on OpenAlexafffund
Matthew T. Menard, Alik Farber, Richard J. Powell, Kenneth Rosenfield, Michael S. Conte, Taye H. Hamza, John A. Kaufman, Mark J. Cziraky, Mark A. Creager, Michael D. Dake, Michael R. Jaff, Diane Reid, George Sopko, Christopher J. White, Michael B. Strong, Max van Over, Emiliano Chisci, Philip P. Goodney, Bruce H. Gray, Ahmed Kayssi, Jeffrey J. Siracuse, Niteesh K. Choudhry, Mick Maurao, Satish C. Muluk, Michael Belkin, Sean P. Lyden, Mehdi H. Shishehbor, Danielle Bajakian, Yazan Duwayri, Nina Bowens, Timothy J. Nypaver, Dipankar Mukherjee, Daniel I. Obrand, Glenn M. LaMuraglia, Manju Kalra, Nelson L. Bernardo, Neal R. Barshes, Evan C. Lipsitz, J. Stephen Jenkins, Warren J. Gasper, Christopher Owens, Frank B. Pomposelli, Kevin Rogers, Ageliki G. Vouyouka, Marc A. Passman, Constantino Peña, Venkatesh G. Ramaiah, John R. Hoch, Robert M. Bersin, Greg Hayes, Karen J. Ho, Aamir Shah, Ying Wie Lum, R. Clement Darling, Oliver Aalami, Wei Zhou, Parag J. Patel, Abdulhameed Aziz, Brian Halloran, Enjae Jung, Erica L. Mitchell, Ulku C. Turba, Eric T. Choi, Jade S. Hiramoto, Ross Milner, Robert S. Crawford, Areck A. Ucuzian, Peter K. Henke, Rabih A. Chaer, Julie Lahiri, Hugh A. Gelabert, Robert D. Safian, Carlos Mena‐Hurtado, Daniel Ihnat, Vincent L. Rowe, Vikram S. Kashyap, Palma M. Shaw, Ethan C Korngold, Thomas F. Lindsay, Gerrit B. Winkelaar, Matthew W. Mell, B. Rubens Duval, Faisal Aziz, Amy B. Reed, Munier Nazzal, Andres Schanzer, Allen D. Hamdan, Matthew R. Smeds, Jeffrey Kalish, Jeffrey M. Slaiby, Mark P. Androes, Tod Hanover, Raghu L. Motaganahalli, Catherine K. Chang, Robert J. Hye, Jason Alexander, Gary M. Ansel, Todd Bohannon, Sapan S. Desai, Kim J. Hodgson, Douglas Hood, Randolph Guzman, Kristina A. Giles, Samir K. Shah, Beau Hawkins, Thomas E. Brothers, Ali Azizzadeh, Kristofer M. Charlton-Ouw, Sophia Khan, Benjamin S. Brooke, Nii-Kabu Kabutey, Ravish Sachar, Hasan H. Dosluoglu, Scott S. Berman, John Blebea, Kevin Taubman, Yvan Douville, Mitchell W. Cox, Joseph Davis, Michael Caps, Peter A. Schneider, Ahmed M. Abou‐Zamzam, Robert Feldman, Gregory Von Mering, Tze‐Woei Tan, Chiranjiv Virk, Wayne Zhang, Michael Bacharach, Craig S. Seidman, Mark D. Iafrati, Laura Findeiss, L. Charles Bailey, Murray L. Shames, John S. Lane, Donald T. Baril, Stephen M. Hass, Patrick A. Stone, Aditya Sharma, Margaret C. Tracci, Kent S. MacKenzie, Michael C. Stoner, Jean E. Starr, David McAllister, Niten Singh, Shirling Tsai, Scott Kinlay, Robyn Macsata, Richard F. Neville, John H. Rundback, Kate McGinigle, Raghu Vallabhaneni, Andrey Espinoza, Amir F. Azarbal, G. Matthew Longo, Richard Kovach, Peter Soukas, Chris Metzger, Andre Artis, William Bachinsky, Ehrin J. Armstrong, Brack Hattler, Venita Chandra, Jonathan Schor, Christian Bianchi, Sharon C. Kiang, Eyal Ben-Arie, Michael J. Verta, Julia Wilkinson, Justin Hurie, David Kopriva, Robert G. Molnar, Linda Chun, Ezana Azene, Clark Davis, Elizabeth Blazick, Steve Henao, Trent Proffitt, C. Peter Herman, Derek P. Nathan, Robert W. Chang, Leila Mureebe, Jerry Yongqiang Chen, Marcus E. Semel, Scott Fecteau, Sudhir Nagpal, Nicolas W. Shammas, Scott W. Kujath, Robert Beasley, Todd R. Vogel, Nasim Hedayati, James Brooks, Peter R. Nelson, Inkyong Parrack, Thomas Bernik, David Dexter, Kellie R. Brown, Joe Huang, Timothy Wu, Robert Hacker, Brandon T. Garland, Joseph Griffin, Igor Laskowski, Steven Pfau, Audra A. Duncan, Jeffrey Trachtenberg, Ian L. Gordon, Bernadette Aulivola, Mohamed A. Zayed, Maarit Venermo, Andrew Hill, Janaka K. Wickremesekera, Erika R. Ketteler, Stefano Michelagnoli, Mohsen Bannazadeh, Nicholas Sikalas, Manar Khashram, Thodur Vasudevan, Justin Simmons, Nicholas H. Osborne, Charles J. Fox, Raghuveer Vallabhaneni

Bibliographic record

VenueCirculation · 2024
Typearticle
Languageen
FieldMedicine
TopicPeripheral Artery Disease Management
Canadian institutionsUniversity of Toronto
FundersNational Heart, Lung, and Blood InstituteVascular SocietyNovo Nordisk FondenAbiomedCanadian Society for Vascular SurgeryNovo NordiskNational Institutes of HealthBoston Scientific Corporation
KeywordsMedicineRevascularizationIschemiaQuality of life (healthcare)CardiologyLimb ischemiaInternal medicineIntensive care medicineMyocardial infarction

Abstract

fetched live from OpenAlex

BACKGROUND: In the BEST-CLI trial (Best Endovascular Versus Best Surgical Therapy for Patients With Chronic Limb-Threatening Ischemia), a prespecified secondary objective was to assess the effects of revascularization strategy on health-related quality of life (HRQoL). METHODS: Patients with chronic limb-threatening ischemia were randomized to surgical bypass (Bypass) or endovascular intervention (Endo) in 2 parallel trials. Cohort 1 included patients with single-segment great saphenous vein; cohort 2 included those lacking suitable single-segment great saphenous vein. HRQoL was assessed over the trial duration using Vascular Quality-of-Life (VascuQoL), European Quality-of-Life-5D (EQ-5D), the Short Form-12 (SF-12) Physical Component Summary (SF-12 PCS), SF-12 Mental Component Summary (SF-12 MCS), Utility Index Score (SF-6D R2), and numeric rating scales of pain. HRQoL was summarized by cohort and compared within and between groups using mixed-model linear regression. RESULTS: A total of 1193 and 335 patients in cohorts 1 and 2 with a mean follow-up of 2.9 and 2.0 years, respectively, were analyzed. In cohort 1, HRQoL significantly improved from baseline to follow-up for both groups across all measures. For example, mean (SD) VascuQoL scores were 3.0 (1.3) and 3.0 (1.2) for Bypass and Endo at baseline and 4.7 (1.4) and 4.8 (1.5) over follow-up. There were significant group differences favoring Endo when assessed with VascuQoL (difference, –0.14 [95% CI, –0.25 to –0.02]; P =0.02), SF-12 MCS (difference, –1.03 [95% CI, –1.89 to –0.18]; P =0.02), SF-6D R2 (difference, –0.01 [95% CI, –0.02 to –0.001]; P =0.03), numeric rating scale pain at present (difference, 0.26 [95% CI, 0.03 to 0.49]; P =0.03), usual level during previous week (difference, 0.26 [95% CI, 0.04 to 0.48]; P =0.02), and worst level during previous week (difference, 0.29 [95% CI, 0.02 to 0.56]; P =0.04). There was no difference between treatment arms on the basis of EQ-5D (difference, –0.01 [95% CI, –0.03 to 0.004]; P =0.12) or SF-12 PCS (difference, –0.41 [95% CI, –1.2 to 0.37]; P =0.31). In cohort 2, HRQoL also significantly improved from baseline to the end of follow-up for both groups based on all measures, but there were no differences between Bypass and Endo on any measure. CONCLUSIONS: Among patients with chronic limb-threatening ischemia deemed eligible for either Bypass or Endo, revascularization resulted in significant and clinically meaningful improvements in HRQoL. In patients with an available single-segment great saphenous vein for bypass, but not among those without one, Endo was statistically superior on some HRQoL measures; however, these differences were below the threshold of clinically meaningful difference.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.283

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.252
Teacher spread0.238 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueCirculationSame topicPeripheral Artery Disease ManagementFrench-language works237,207